Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Elisa Rumi, Emanuela Boveri, Marta Bellini, Daniela Pietra, Virginia V. Ferretti, Emanuela Sant’Antonio, Chiara Cavalloni, Ilaria C. Casetti, Elisa Roncoroni, Michele Ciboddo, Pietro Benvenuti, Benedetta Landini, Elena Fugazza, Daniela Troletti, Cesare Astori, Mario Cazzola, on Behalf of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators
Published Oct 6, 2017 · Vol. 8, No. 60 · pp. 101735-101744
Fabiana M. Meliso, Danilo Micali, Camila T. Silva, ThaÃs S. Sabedot, Simon G. Coetzee, Adrian Koch, Fabian B. Fahlbusch, Houtan Noushmehr, Regine Schneider-Stock, Miriam G. Jasiulionis
Published Oct 3, 2017 · Vol. 8, No. 70 · pp. 114540-114553
Dominik Klumpp, Stephanie C. Frank, Lukas Klumpp, Efe C. Sezgin, Marita Eckert, Lena Edalat, Martin Bastmeyer, Daniel Zips, Peter Ruth, Stephan M. Huber
Published Sep 30, 2017 · Vol. 8, No. 56 · pp. 95896-95913
